Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.

Zhao K, Chen G, Shi XM, Gao TT, Li W, Zhao Y, Zhang FQ, Wu J, Cui X, Wang YF.

PLoS One. 2012;7(12):e53314. doi: 10.1371/journal.pone.0053314.

2.

O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.

Dai C, Kang H, Yang W, Sun J, Liu C, Cheng G, Rong G, Wang X, Wang X, Jin Z, Zhao K.

Carbohydr Polym. 2015 Oct 5;130:280-9. doi: 10.1016/j.carbpol.2015.05.008.

PMID:
26076628
3.

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.

Zhao K, Zhang Y, Zhang X, Li W, Shi C, Guo C, Dai C, Chen Q, Jin Z, Zhao Y, Cui H, Wang Y.

Int J Nanomedicine. 2014;9:389-402. doi: 10.2147/IJN.S54226.

4.

[Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].

Zhai RL, Xu HY, Wang YL, Qin ZM, Jiang SJ.

Wei Sheng Wu Xue Bao. 2007 Aug;47(4):692-6. Chinese.

PMID:
17944374
5.
6.

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles.

Zhao K, Li W, Huang T, Luo X, Chen G, Zhang Y, Guo C, Dai C, Jin Z, Zhao Y, Cui H, Wang Y.

PLoS One. 2013 Dec 26;8(12):e82648. doi: 10.1371/journal.pone.0082648.

7.

Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.

Esaki M, Godoy A, Rosenberger JK, Rosenberger SC, Gardin Y, Yasuda A, Dorsey KM.

Avian Dis. 2013 Dec;57(4):750-5.

PMID:
24597117
8.

Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.

Zhao K, Zhang Y, Zhang X, Shi C, Wang X, Wang X, Jin Z, Cui S.

Int J Nanomedicine. 2014 Sep 30;9:4609-19. doi: 10.2147/IJN.S70633.

9.

Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus.

Winterfield RW, Dhillon AS, Alby LJ.

Poult Sci. 1980 Feb;59(2):240-6.

PMID:
7413554
10.
11.

Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.

Swayne DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastre A.

Avian Dis. 2003;47(3 Suppl):1047-50.

PMID:
14575108
12.

Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.

Yang X, Zhou Y, Li J, Fu L, Ji G, Zeng F, Zhou L, Gao W, Wang H.

Arch Virol. 2016 May;161(5):1209-16. doi: 10.1007/s00705-016-2764-4.

PMID:
26873815
14.
15.

Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.

Reddy SK, Sharma JM, Ahmad J, Reddy DN, McMillen JK, Cook SM, Wild MA, Schwartz RD.

Vaccine. 1996 Apr;14(6):469-77.

PMID:
8782342
16.
17.

Immune responses of poultry to Newcastle disease virus.

Kapczynski DR, Afonso CL, Miller PJ.

Dev Comp Immunol. 2013 Nov;41(3):447-53. doi: 10.1016/j.dci.2013.04.012. Review.

18.

Development of a virosome vaccine for Newcastle disease virus.

Kapczynski DR, Tumpey TM.

Avian Dis. 2003 Jul-Sep;47(3):578-87.

PMID:
14562884
19.

Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.

Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, Prajitno TY, Bharoto EE, Collins PL, Samal SK.

PLoS One. 2012;7(12):e52751. doi: 10.1371/journal.pone.0052751.

Items per page

Supplemental Content

Support Center